aluates Reports

$ 0.0

Automative

Global Glucagon-like Peptide-1 Receptor Agonist Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-4A6089

Global Glucagon like Peptide 1 Receptor Agonist Market Insights and Forecast to 2028

BUY CHAPTERS

Global Glucagon-like Peptide-1 Receptor Agonist Market Insights, Forecast to 2030

Code: QYRE-Auto-4A6089

Report

December 2024

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Glucagon-like Peptide-1 Receptor Agonist Market Size

The global Glucagon-like Peptide-1 Receptor Agonist market is projected to grow from US$ 10090 million in 2024 to US$ 21040 million by 2030, at a Compound Annual Growth Rate (CAGR) of 13.0% during the forecast period.

Glucagon-like Peptide-1 Receptor Agonist Market

Market Analysis and Insights: Global Glucagon-like Peptide-1 Receptor Agonist Market

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Covers:

This report presents an overview of global market for Glucagon-like Peptide-1 Receptor Agonist market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Glucagon-like Peptide-1 Receptor Agonist, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Glucagon-like Peptide-1 Receptor Agonist, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Glucagon-like Peptide-1 Receptor Agonist revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Glucagon-like Peptide-1 Receptor Agonist market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Glucagon-like Peptide-1 Receptor Agonist revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Glucagon-like Peptide-1 Receptor Agonist Market Report

Report Metric	Details
Report Name	Glucagon-like Peptide-1 Receptor Agonist Market
Accounted market size in 2024	US$ 10090 million
Forecasted market size in 2030	US$ 21040 million
CAGR	13.0
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Exenatide Liraglutide Lixisenatide Albiglutide Others
Segment by Application	Solid Tumors Blood-related Tumors
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Novo Nordisk, Lily, Haosoh, Sanofi, AstraZeneca
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Glucagon-like Peptide-1 Receptor Agonist in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glucagon-like Peptide-1 Receptor Agonist companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glucagon-like Peptide-1 Receptor Agonist revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Glucagon-like Peptide-1 Receptor Agonist Market growing?

Ans: The Glucagon-like Peptide-1 Receptor Agonist Market witnessing a CAGR of 13.0 during the forecast period 2025-2030.

What is the Glucagon-like Peptide-1 Receptor Agonist Market size in 2030?

Ans: The Glucagon-like Peptide-1 Receptor Agonist Market size in 2030 will be US$ 21040 million.

Who are the main players in the Glucagon-like Peptide-1 Receptor Agonist Market report?

Ans: The main players in the Glucagon-like Peptide-1 Receptor Agonist Market are GSK, Novo Nordisk, Lily, Haosoh, Sanofi, AstraZeneca

What are the Application segmentation covered in the Glucagon-like Peptide-1 Receptor Agonist Market report?

Ans: The Applications covered in the Glucagon-like Peptide-1 Receptor Agonist Market report are Solid Tumors, Blood-related Tumors

What are the Type segmentation covered in the Glucagon-like Peptide-1 Receptor Agonist Market report?

Ans: The Types covered in the Glucagon-like Peptide-1 Receptor Agonist Market report are Exenatide, Liraglutide, Lixisenatide, Albiglutide, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Glucagon-like Peptide-1 Receptor Agonist Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Exenatide

1.2.3 Liraglutide

1.2.4 Lixisenatide

1.2.5 Albiglutide

1.2.6 Others

1.3 Market by Application

1.3.1 Global Glucagon-like Peptide-1 Receptor Agonist Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Solid Tumors

1.3.3 Blood-related Tumors

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Glucagon-like Peptide-1 Receptor Agonist Market Perspective (2019-2030)

2.2 Global Glucagon-like Peptide-1 Receptor Agonist Growth Trends by Region

2.2.1 Glucagon-like Peptide-1 Receptor Agonist Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Glucagon-like Peptide-1 Receptor Agonist Historic Market Size by Region (2019-2024)

2.2.3 Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Region (2025-2030)

2.3 Glucagon-like Peptide-1 Receptor Agonist Market Dynamics

2.3.1 Glucagon-like Peptide-1 Receptor Agonist Industry Trends

2.3.2 Glucagon-like Peptide-1 Receptor Agonist Market Drivers

2.3.3 Glucagon-like Peptide-1 Receptor Agonist Market Challenges

2.3.4 Glucagon-like Peptide-1 Receptor Agonist Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Glucagon-like Peptide-1 Receptor Agonist by Players

3.1.1 Global Glucagon-like Peptide-1 Receptor Agonist Revenue by Players (2019-2024)

3.1.2 Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Players (2019-2024)

3.2 Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Glucagon-like Peptide-1 Receptor Agonist, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Glucagon-like Peptide-1 Receptor Agonist Market Concentration Ratio

3.4.1 Global Glucagon-like Peptide-1 Receptor Agonist Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Glucagon-like Peptide-1 Receptor Agonist Revenue in 2023

3.5 Global Key Players of Glucagon-like Peptide-1 Receptor Agonist Head office and Area Served

3.6 Global Key Players of Glucagon-like Peptide-1 Receptor Agonist, Product and Application

3.7 Global Key Players of Glucagon-like Peptide-1 Receptor Agonist, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Glucagon-like Peptide-1 Receptor Agonist Breakdown Data by Type

4.1 Global Glucagon-like Peptide-1 Receptor Agonist Historic Market Size by Type (2019-2024)

4.2 Global Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Type (2025-2030)

5 Glucagon-like Peptide-1 Receptor Agonist Breakdown Data by Application

5.1 Global Glucagon-like Peptide-1 Receptor Agonist Historic Market Size by Application (2019-2024)

5.2 Global Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Glucagon-like Peptide-1 Receptor Agonist Market Size (2019-2030)

6.2 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type

6.2.1 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2019-2024)

6.2.2 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2025-2030)

6.2.3 North America Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2019-2030)

6.3 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application

6.3.1 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2019-2024)

6.3.2 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2025-2030)

6.3.3 North America Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2019-2030)

6.4 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country

6.4.1 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2019-2024)

6.4.3 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size (2019-2030)

7.2 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type

7.2.1 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2019-2024)

7.2.2 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2025-2030)

7.2.3 Europe Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2019-2030)

7.3 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application

7.3.1 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2019-2024)

7.3.2 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2025-2030)

7.3.3 Europe Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2019-2030)

7.4 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country

7.4.1 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2019-2024)

7.4.3 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Glucagon-like Peptide-1 Receptor Agonist Market Size (2019-2030)

8.2 China Glucagon-like Peptide-1 Receptor Agonist Market Size by Type

8.2.1 China Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2019-2024)

8.2.2 China Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2025-2030)

8.2.3 China Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2019-2030)

8.3 China Glucagon-like Peptide-1 Receptor Agonist Market Size by Application

8.3.1 China Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2019-2024)

8.3.2 China Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2025-2030)

8.3.3 China Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Glucagon-like Peptide-1 Receptor Agonist Market Size (2019-2030)

9.2 Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Type

9.2.1 Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2019-2024)

9.2.2 Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2025-2030)

9.2.3 Asia Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2019-2030)

9.3 Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Application

9.3.1 Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2019-2024)

9.3.2 Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2025-2030)

9.3.3 Asia Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2019-2030)

9.4 Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Region

9.4.1 Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Region (2019-2024)

9.4.3 Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type

10.2.1 Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application

10.3.1 Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country

10.4.1 Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK Business Overview

11.1.3 GSK Glucagon-like Peptide-1 Receptor Agonist Introduction

11.1.4 GSK Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024)

11.1.5 GSK Recent Developments

11.2 Novo Nordisk

11.2.1 Novo Nordisk Company Details

11.2.2 Novo Nordisk Business Overview

11.2.3 Novo Nordisk Glucagon-like Peptide-1 Receptor Agonist Introduction

11.2.4 Novo Nordisk Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024)

11.2.5 Novo Nordisk Recent Developments

11.3 Lily

11.3.1 Lily Company Details

11.3.2 Lily Business Overview

11.3.3 Lily Glucagon-like Peptide-1 Receptor Agonist Introduction

11.3.4 Lily Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024)

11.3.5 Lily Recent Developments

11.4 Haosoh

11.4.1 Haosoh Company Details

11.4.2 Haosoh Business Overview

11.4.3 Haosoh Glucagon-like Peptide-1 Receptor Agonist Introduction

11.4.4 Haosoh Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024)

11.4.5 Haosoh Recent Developments

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Glucagon-like Peptide-1 Receptor Agonist Introduction

11.5.4 Sanofi Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024)

11.5.5 Sanofi Recent Developments

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Glucagon-like Peptide-1 Receptor Agonist Introduction

11.6.4 AstraZeneca Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024)

11.6.5 AstraZeneca Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Glucagon-like Peptide-1 Receptor Agonist Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Exenatide

Table 3. Key Players of Liraglutide

Table 4. Key Players of Lixisenatide

Table 5. Key Players of Albiglutide

Table 6. Key Players of Others

Table 7. Global Glucagon-like Peptide-1 Receptor Agonist Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 8. Global Glucagon-like Peptide-1 Receptor Agonist Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Glucagon-like Peptide-1 Receptor Agonist Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Region (2019-2024)

Table 11. Global Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Region (2025-2030)

Table 13. Glucagon-like Peptide-1 Receptor Agonist Market Trends

Table 14. Glucagon-like Peptide-1 Receptor Agonist Market Drivers

Table 15. Glucagon-like Peptide-1 Receptor Agonist Market Challenges

Table 16. Glucagon-like Peptide-1 Receptor Agonist Market Restraints

Table 17. Global Glucagon-like Peptide-1 Receptor Agonist Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Share by Players (2019-2024)

Table 19. Global Top Glucagon-like Peptide-1 Receptor Agonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon-like Peptide-1 Receptor Agonist as of 2023)

Table 20. Global Glucagon-like Peptide-1 Receptor Agonist Industry Ranking 2022 VS 2023 VS 2024

Table 21. Global 5 Largest Players Market Share by Glucagon-like Peptide-1 Receptor Agonist Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Glucagon-like Peptide-1 Receptor Agonist, Headquarters and Area Served

Table 23. Global Key Players of Glucagon-like Peptide-1 Receptor Agonist, Product and Application

Table 24. Global Key Players of Glucagon-like Peptide-1 Receptor Agonist, Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Type (2019-2024)

Table 28. Global Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Type (2025-2030)

Table 30. Global Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Share by Application (2019-2024)

Table 32. Global Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Share by Application (2025-2030)

Table 34. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Glucagon-like Peptide-1 Receptor Agonist Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Glucagon-like Peptide-1 Receptor Agonist Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Glucagon-like Peptide-1 Receptor Agonist Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Glucagon-like Peptide-1 Receptor Agonist Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2025-2030) & (US$ Million)

Table 66. GSK Company Details

Table 67. GSK Business Overview

Table 68. GSK Glucagon-like Peptide-1 Receptor Agonist Product

Table 69. GSK Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024) & (US$ Million)

Table 70. GSK Recent Developments

Table 71. Novo Nordisk Company Details

Table 72. Novo Nordisk Business Overview

Table 73. Novo Nordisk Glucagon-like Peptide-1 Receptor Agonist Product

Table 74. Novo Nordisk Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024) & (US$ Million)

Table 75. Novo Nordisk Recent Developments

Table 76. Lily Company Details

Table 77. Lily Business Overview

Table 78. Lily Glucagon-like Peptide-1 Receptor Agonist Product

Table 79. Lily Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024) & (US$ Million)

Table 80. Lily Recent Developments

Table 81. Haosoh Company Details

Table 82. Haosoh Business Overview

Table 83. Haosoh Glucagon-like Peptide-1 Receptor Agonist Product

Table 84. Haosoh Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024) & (US$ Million)

Table 85. Haosoh Recent Developments

Table 86. Sanofi Company Details

Table 87. Sanofi Business Overview

Table 88. Sanofi Glucagon-like Peptide-1 Receptor Agonist Product

Table 89. Sanofi Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024) & (US$ Million)

Table 90. Sanofi Recent Developments

Table 91. AstraZeneca Company Details

Table 92. AstraZeneca Business Overview

Table 93. AstraZeneca Glucagon-like Peptide-1 Receptor Agonist Product

Table 94. AstraZeneca Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024) & (US$ Million)

Table 95. AstraZeneca Recent Developments

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Glucagon-like Peptide-1 Receptor Agonist Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Type: 2023 VS 2030

Figure 3. Exenatide Features

Figure 4. Liraglutide Features

Figure 5. Lixisenatide Features

Figure 6. Albiglutide Features

Figure 7. Others Features

Figure 8. Global Glucagon-like Peptide-1 Receptor Agonist Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Application: 2023 VS 2030

Figure 10. Solid Tumors Case Studies

Figure 11. Blood-related Tumors Case Studies

Figure 12. Glucagon-like Peptide-1 Receptor Agonist Report Years Considered

Figure 13. Global Glucagon-like Peptide-1 Receptor Agonist Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Glucagon-like Peptide-1 Receptor Agonist Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Region: 2023 VS 2030

Figure 16. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Players in 2023

Figure 17. Global Top Glucagon-like Peptide-1 Receptor Agonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon-like Peptide-1 Receptor Agonist as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Glucagon-like Peptide-1 Receptor Agonist Revenue in 2023

Figure 19. North America Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2019-2030)

Figure 21. North America Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2019-2030)

Figure 22. North America Glucagon-like Peptide-1 Receptor Agonist Market Share by Country (2019-2030)

Figure 23. United States Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2019-2030)

Figure 27. Europe Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2019-2030)

Figure 28. Europe Glucagon-like Peptide-1 Receptor Agonist Market Share by Country (2019-2030)

Figure 29. Germany Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Glucagon-like Peptide-1 Receptor Agonist Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2019-2030)

Figure 37. China Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2019-2030)

Figure 38. Asia Glucagon-like Peptide-1 Receptor Agonist Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2019-2030)

Figure 40. Asia Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2019-2030)

Figure 41. Asia Glucagon-like Peptide-1 Receptor Agonist Market Share by Region (2019-2030)

Figure 42. Japan Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Glucagon-like Peptide-1 Receptor Agonist Market Share by Country (2019-2030)

Figure 52. Brazil Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GSK Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024)

Figure 59. Novo Nordisk Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024)

Figure 60. Lily Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024)

Figure 61. Haosoh Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024)

Figure 62. Sanofi Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024)

Figure 63. AstraZeneca Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2019-2024)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions